Effect of host age on tumor growth rate in rodents

Frontiers in Bioscience

Volumn 11, Issue 1 P.1-446, 2006, Pages 412-422

  Anisimov, Vladimir N ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

Aging; Cancer; Host Tumor Interaction; Mouse; Neoplasia; Rat; Review; Senescence; Tumor

Indexed keywords

ANIMALIA; RODENTIA;

EID: 32844454604     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1808     Document Type: Review

References (78)

1. Ershler W.B., R.L. Gamelli, A.L. Moore, M.P. Hacker and A.J. Blow: Experimental tumors and aging: local factors that may account for the observed age advantage in the B16 murine melanoma model. Exp Gerontol 19, 367-376 (1984)
2. Ershler W.B., J.A. Steward, M.P. Hacjer, A.L. Moore and B.H. Tindle: B16 murine melanoma and aging: slower growth and longer survival in old mice. J Natl Cancer Inst 72, 161-164 (1984)
3. Ershler W.B.: Explanations for reduced tumor proliferative capacity with age. Exp Gerontol 27, 551-558 (1992)
4. Ershler W.B.: Tumor-host interactions, aging, and tumor growth. In: Comprehensive Geriatric Oncology. Eds: Balducci L., Lyman G.H., Ershler W.B. and Extermann M. Taylor and Francis Group, London 147-157 (2004)
5. Campisi J.: Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 11, 27-31 (2001)
6. Campisi J.: Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes. Exp Gerontol 38, 5-11 (2003)
7. Campisi J.: Aging, tumor suppression and cancer: high wire-act! Mech Ageing Dev 126, 51-58 (2005)
8. Krtolica A., S. Parinello, S. Lockett, P.Y. Desprez and J. Campisi: Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 98, 12072-12077 (2001)
9. Krtolica A. and J. Campisi: Integrating epithelial cancer, aging stroma and cellular senescence. Adv Gerontol 11, 109-116 (2003)
10. Balducci L.: Geriatric oncology. Crit Rev Oncol Hematol 46, 211-220 (2003)
11. Holmes F.F. Clinical evidence for change in tumor aggressiveness with age: A historical perspective. In: Comprehensive Geriatric Oncology. Eds: Balducci L., Lyman G.H., Ershler W.B. and Extermann M. Taylor and Francis Group London, 180-186 (2004)
12. Gospodarowicz M.K., D.E. Henson, R.V.P. Hutter, B. O'Sullivan, L.H. Sobin and Ch. Wittekind: Eds: Prognostic Factors in Cancer, 2nd Edition., Geneva: UICC (2001)
13. Blinov N.N.: Age as a factor of prognisis in cancer. In: Cancer in the Elderly. Eds: Anisimov V.N., Moisseyenko V.M., Hanson K.P. St.Petersburg 138-151 (2004)
14. Anisimov V.N.: Carcinogenesis and Aging. Vol. 2. CRC Press, Boca Raton (1987)
15. Anisimov V.N.: The relationship between aging and carcinogenesis: a critical appraisal. Crit Rev Oncol Hematol 45, 277-304 (2003)
16. Anisimov V.N.: Age as a risk factor in multistage carcinogenesis. In: Comprehensive Geriatric Oncology. Eds: Balducci L, Lyman GH, Ershler WB and Extermann M. Taylor and Francis Group, London 75-101 (2004)
17. Peto R., F.J.C. Roe, P.N. Lee, L. Levy and J. Clack: Cancer and ageing in mice and men. Br J Cancer 32, 411-426 (1975)
18. Burnet F.M. Innmunology, Aging and Cancer. Medical Aspects of Mutation and Selection. Freeman and Co, San Francisco (1976)
19. Thompson S.C.: Effect of age and sex on lung colony forming efficiency of injected mouse tumour cells. Br J Cancer 34, 566-770 (1976)
20. Yuhas J.M. and R.L. Ullrich: Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum. Cancer Res 36, 161-166 (1976)
21. Gozes Y. and N. Trainin: Enhancement of Lewis lung carcinoma in a syngeneic host by spleen cells of C57BL/6 old mice. Eur J Immunol 7, 159-164 (1977)
22. Anisimov V.N. and N.V. Zhukovskaya: Effect of age on the growth of transplantable tumors in mice. Vopr Onkol 27(8), 52-59 (1981)
23. Sadovnikova I.P., L.K. Obukhova, T.V. Bunto and L.D. Smirnov: Effect of age on kinetics of development of spontaneous and transplanted tumors and on the effectivity of chemotherapy, Izv Acad Nauk SSSR, Ser Biol 2, 543-550 (1984)
24. Hirayama R., K. Hirokawa and T. Makinodan: Change of metastatic mode of B16 malignant melanoma in C57BL/6 mice by aging and sex. In: Age-Related Factors in Carcinogenesis, IARC Sci. Publ. No. 58. Eds: Likhachev A., Anisimov V., Montesano R. IARC, Lyon 85-96 (1985)
25. Ehrlich R., N. Smorodinsky, M. Efrati, M. Yakubowicz and I.P. Witz: B16 melanoma development, NK activity and natural antibodies in 3 and 12 months old mice. Br J Cancer 49, 769-777 (1984)
26. Baumgart J., N.V. Zhukovskaya and V.N. Anisimov: Carcinogenesis and aging. VIII. Effect of host age on tumour growth, metastatic potential, and chemotherapeutic sensitivity to 1,4-benzoquinone-guanylhydrazone thiosemicarbazone (ambazone) and 5-fluorouracil in mice and rats. Exp Pathol 33, 239-248 (1988)
27. Hirayama R., K. Takemura, Z. Nihei, W. Ichikawa, Y. Takagi, Y. Mishima, M. Utsuyama and K. Hirokawa: Differential effect of host microenvironment and systemic humoral factors on the implantation and the growth rate of metastatic tumor in parabiotic mice constructed between young and old mice. Mech Ageing Dev 71, 213-221 (1993)
28. Pili R., Y. Guo, J. Chang, H. Nakanishi, G.R. Martin and A. Passaniti: Altered angiogenesis underlying age-dependent changes in tumor growth. J Natl Cancer Inst 86, 1303-1314 (1994)
29. Donin N., J. Sinai, A. Staroselsky, T. Mahlin, J. Nordenberg and J. Leibovici: Comparison of growth rate of two B16 melanomas differing in metastatic potential in young versus middle-aged mice. Cancer Invest 15, 416-421 (1997)
30. Kaptzan T., E. Skutelsky, O. Itzhaki, J. Sinai, M. Mechowitz, Y. Yossipov, G. Schiby and J. Leibovici: Age-dependent differences in the efficacy of cancer immunotherapy in C57BL and AKR mouse strains. Exp Gerontol 39, 1035-1048 (2004)
31. Itzhaki O., E. Skutelsky, T. Kaptzan, J. Sinai, M. Michowitz, M. Huszar and J. Leibovici: Ageing-apoptosis relation in murine spleen. Mech Ageing Dev 124, 999-1012 (2003)
32. Itzhaki O., T. Kaptzan, E. Skutelsky, J. Sinai, M. Michowitz, A. Siegal, G. Schibi, M. Huszar, L. Ben-Dor and J. Leibovici: Age-adjusted antitumoral therapy based on the demonstration of increased apoptosis as a mechanism underlying the reduced malignancy of tumors in the aged. Biochim Biophys Acta 1688, 145-159 (2004)
33. Aoki T., M.N. Teller and M-L. Robitaille: Aging and carcinogenesis. II. Effect of age on phagocytic activity of the reticuloendothelial system and on tumor growth. J Natl Cancer Inst 34, 255-264 (1965)
34. Rockwell, S.: Effect of host age on the transplantation, growth, and radiation response of EMT6 tumors. Cancer Res 41, 527-531 (1981)
35. Gravekamp C., R. Sypniewska and L. Hoflack: The usefulness of mouse breast tumor models for testing and optimization of breast cancer vaccines at old age. Mech Ageing Dev 125, 125-127 (2004)
36. Gravekamp C., R. Sypniewska, S. Gaunte, M. Tarango, P. Price and R. Reddick: Behavior of metastatic and nonmetastatic breast tumors in old mice. Exp Biol Med 229, 665-675 (2004)
37. Bellami D. and S.M. Hinsull: Effect of host age on the growth and mitotic index of experimental tumors in laboratory rat. J Clin Exp Gerontol 1, 57-77 (1979)
38. McCullough K.D., W.B. Coleman, G.J. Smith and J.W. Grisham: Age-dependent regulation of the tumorigenic potential of neoplastically transformed rat liver epithelial cells by the liver microenvironment. Cancer Res 54, 3668-3671 (1994)
39. McCullough K.D., W.B. Coleman, G.J. Smith and J.W. Grisham: Age-dependent induction of hepatic tumor regression by the tissue microenvironment after transplantation of neoplastically transformed rat liver epithelial cells into the liver. Cancer Res 57, 1807-1813 (1997)
40. McCullough K.D., W.B. Coleman, S.L. Ricketts, J.W. Wilson, G.J. Smith and L.W. Grisham: Plasticity of the neoplastic phenotype n vivo is regulated by epigenetic factors. Proc Natl Acad Sci USA 95, 15333-15338 (1998)
41. Coleman W.B., A.E. Wennerberg, G.J. Smith and J.W. Grisham: Regulation of the differentiation of diploid and some aneuploid rat liver epithelial (stem-like) cells by the hepatic microenvironment. Am J Pathol 142, 1373-1382 (1993)
42. Maruo K., Y. Ueyama, Y. Kuwahara, K. Hioki, M. Saito, T. Nomura and N. Tamaoki: Human tumour xenografts in athymiv rats and their age dependence. Br J Cancer 45, 786-789 (1982)
43. Pozharisski K.M., L.G. Prvanova, V.N. Anisimov and V.F. Klimashevski. Effect of ageing on colon carcinogenesis. Exp Oncol 2(2), 20-22 (1980)
44. Turusov V.S., N.S. Lanko and Yu.D. Parfenov. Influence of age on induction of colon tumors in mice by 1,2-dimethylhysrazine. Bull Exp Biol Med 92, 705-707 (1981)
45. Kubota K., R. Kubota, S. Takeda and T. Matsuzawa: Effect of age and sex of host mice on growth and differentiation of teratocarcinoma OTT6050. Exp Gerontol 16, 371-384 (1981)
46. Teller M.N., G. Stohr, W. Curlett, M.L. Kubisek and D. Curtis: Aging and carcinogenesis. I. Immunity to tumor and skin grafts. J Natl Cancer Inst 33, 649-656 (1964)
47. Perkins E.H.: A multiple parameter comparison of immunocompetence and tumor resistance in aged BALB/c mice. Mech Ageing Dev 6, 15-24 (1977)
48. Teller M.N., M. Bowie and I.M. Mountain: Influence of age of host on the chemotherapy of murine myeloma LCP-1. J Gerontol 29, 360-365 (1974)
49. Goldin A., J.M. Vendetti and S.R. Humphreys: Factors influencing the specificity of action of an antileukemic agent (aminopterin): host age and weight. J Natl Cancer Inst 16, 709-721 (1955)
50. Rodriguez P.E., Y.P. De Bonaparte, L. D'Elia and D. Klein: Studies on NZB mice. III. Failure of growth of isogeneic tumors transplanted to old NZB mice. Sangre 21, 805-813 (1976)
51. Loefer J.B.: Effect of age of the donor on development of rat rumor grafts. Cancer 5, 163-165 (1952)
52. Keller R.: Reduced spontaneous antitumor resistance of the elderly rat is restored by Corynebacterium parvum. Br. J Cancer 38, 557-560 (1978)
53. Hollingsworth M.A., J. Barrowclough and D.L. Evans: Age-related increases in mitogenic responses and natural immunity to a syngeneic fibrosarcoma in rats. Mech Ageing Dev 14, 95-106 (1981)
54. Hollingsworth M.A. and D.L. Evans: Changes in spleen cell proliferative responses and resistance to syngeneic tumor challenge in aging NBR rats. Mech Ageing Dev 22, 321-333 (1983)
55. Stjernward J.: Age-dependent tumor-host barrier and effect of carcinogen-induced immunodepression on rejection of isografted methylcholanthrene-induced sarcoma cells. J Natl Cancer Inst 37, 505-512 (1966)
56. Tagliabue A., W. Luini, G. De Vito and D. Boraschi: Effect of the age-related immune depression induced by MTV on in vivo growth of a mammary carcinoma. Br J Cancer 44, 460-463 (1981)
57. Flood P.M., J.L. Urban, M.L. Kripke and H. Schreiber: Loss of tumor-specific and idiotype-specific immunity with age. J Exp Med 154, 275-290 (1981)
58. Bazlova L.S.: Transplantation of uterine sarcoma induced in CBA mice by 1,2-dimethylhydrazine. Vopr Onkol 9, 80-82 (1978)
59. Anisimov V.N., N.V. Zhukovskaya, A.S. Loktionov and Yu.B. Vakhtin: Influence of host age on lung colony forming capacity of injected rat rhabdomyosarcoma cells. Cancer Lett 40, 77-82 (1988)
60. Bums E.A. and J.S. Goodwing: Immunological changes of aging. In: Comprehensive Geriatric Oncology. Eds: Balducci L., Lyman G.H., Ershler W.B. and Extermann M, Taylor and Francis Group, London, 158-170 (2004)
61. Kreisle R.A., B.A. Stebler and W.B. Ershler: Effect of host age on tumor- associated angiogenesis in mice. J Natl Cancer Inst 82, 44-47 (1990)
62. Goodman S.A. and T. Makinodan. Effect of age on cell-mediated immunity in long-lived mice. Clin Exp Immunol 19, 533-542 (1975)
63. Park C.C., M.J. Bissell and M. Barcellos-Hoff: The influence of the microenvironment on the malignant phenotype. Mol Med Today 6, 324-329 (2000)
64. Liotta L.A. and E.G. Kohn. The microenvironment of the tumor-host interface. Nature 411, 375-379 (2001)
65. Dilman V.M.: Development, Aging and Disease. A New Rationale for an Intervention Strategy. Chur: Harwood Academic Publ (1994)
66. Fernandez-Pol J.A.: Growth factors, oncogenes, and aging. In: Comprehensive Geriatric Oncology. Eds: Balducci L, Lyman GH, Ershler WB and Extermann M.: Taylor and Francis Group., London 102-126 (2004)
67. Hornebeck W., H. Emonard, J.C. Monboisse and G. Bellon: Matrix-directed regulation of pericellular proteolysis and tumor progression. Sem Cancer Biol 12, 231-241 (2002)
68. Robert L.: Cell-matrix interactions in cancer spreading - effect of aging. Sem Cancer Biol 12, 157-163 (2002)
69. Robert L. and J. Labat-Robert: Aging of connective tissues: from genetic to epigenetic mechanisms. Biogerontology 1, 123-131 (2001)
70. Itahana K., J. Campisi and G.P. Dimri: Mechanisms of cellular senescence in human and mouse cells. Biogerontology 5, 1-10 (2004)
71. Ershler W.B. and D.L. Longo: The biology of aging. The current research agenda. Cancer 80, 1284-1293 (1997)
72. Bergers G. and L.E. Benjamin: Tumorigenesis and the angiogenic switch. Nature Rev Cancer 3, 401-410 (2003)
73. Franco S., I. Segura, H.H. Riese and M.A. Blasco: Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres. Cancer Res 62, 552-559 (2002)
74. Nickoloff B.J., M.W. Lingen, B.D. Chang, M. Shen, M. Swift, J. Curry, P. Bacon, B. Bodner and I.B. Roninson: Tumor suppressor mapsin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. Cancer Res 64, 5. 2956-2961 (2004)
75. Anisimov V.N. Carcinogenesis and aging. Adv Cancer Res 40, 365-424 (1983)
76. DePinho R.A.: The age of cancer. Nature 408, 248-254 (2000)
77. Shapot V.S. and V.P. Shelepov: Interrelations and trigger mechanisms of homeostatic disorders in a tumor-bearing host. Arkh Pathol 45(8), 3-12 (1983)
78. Auerbach R. and W. Auerbach: Regional differences in the growth of normal and neoplastic cells. Sciences 215, 127-134 (1982)